Skip to content

ALBIREO PHARMA, INC.

CIK 0001322505

← back to feed
Revenue (TTM)
$28.53M
+388.4% YoY Q3 Nov 2022
Net Income (TTM)
−$63.1M
+68.4% YoY Q3 Nov 2022
EPS Diluted (TTM)
−$3.25
+73.7% YoY Q3 Nov 2022
Gross Margin
137.5%
Q3 Nov 2022
Operating Margin
-527.8%
Q3 Nov 2022
Net Margin
-221.1%
Q3 Nov 2022
Free Cash Flow (TTM)
−$107.82M
Q3 Nov 2022
Cash
$222.48M
Q3 Nov 2022
Total Debt
$1.47M
Q3 Nov 2022
Shares Outstanding
20.7M sh
Q3 Nov 2022

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings